Results 1 to 10 of about 35,320 (249)
Preregistration of high‐quality protocols in pharmacoepidemiology research [PDF]
JCPP AdvancesPharmacoepidemiology studies are an important complement to Randomized Clinical trials, but such studies face several challenges, such as confounding and selective reporting.
Henrik Larsson +2 more
doaj +2 more sources
Pharmacoepidemiology: An Overview
Journal of Clinical Medicine, 2023 The aims of this review are to provide a comprehensive overview of the definition and scope of pharmacoepidemiology, to summarize the study designs and methodologies used in the field, to discuss the future trends in the field and new methodologies to address bias and confounding, and finally to give some recommendations to clinicians interested in ...
Mònica Sabaté, Eva Montané
exaly +6 more sources
Clinical Therapeutics, 2019 At the time of their marketing authorization, the effects of drugs and especially their efficacy have been mostly studied in randomized controlled clinical trials (RCT), comparing them to placebo or to existing drugs. However, RCT are by nature limited in their extent, and the often stringent inclusion and exclusion criteria destined to provide for ...
Nicholas, Moore +2 more
+7 more sources
JID Innovations, 2023 The U.S. Food and Drug Administration and clinical guidelines use evidence from pharmacoepidemiology studies to inform prescribing decisions and fill evidence gaps left by randomized controlled trials (RCTs).
Sebastian Schneeweiss +1 more
doaj +1 more source
Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensive Overview
Pharmacoepidemiology, 2023 The pandemic outbreak of Coronavirus disease 2019 (COVID-19) has drastically changed the picture of global healthcare. With the rapid emergence of novel variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that rendered the currently ...
Suneetha Vuppu +2 more
doaj +1 more source
Pharmacoepidemiology, 2023 Introduction: Given the increasing adult use of amphetamine and methylphenidate and their high misuse potential, we examined suspected suicide attempts and other intentional misuse and medical outcomes and their associations with co-used other substances
Namkee G. Choi +2 more
doaj +1 more source
Respiratory Research, 2021 Background Real-world data regarding outcomes of idiopathic pulmonary fibrosis (IPF) are scarce, outside of registries. In France, pirfenidone and nintedanib are only reimbursed for documented IPF, with similar reimbursement criteria with respect to ...
Manon Belhassen +3 more
doaj +1 more source
Pharmacoepidemiology, 2023 Background: The coronavirus pandemic has led to the creation of clinical guidelines by a large number of professional medical communities. However, the quality and methodology of development of Russian clinical guidelines has been little studied.
Elena A. Baybulatova +4 more
doaj +1 more source
Saudi Pharmaceutical Journal, 2018 Background: Pharmacoepidemiology is the concept used for evaluating the impact of drugs among a large number of people in the post-marketing phase. The use of this concept makes it increasingly necessary to detect the recurrence of drug-related anomalies
Ashraf El-Metwally
doaj +1 more source